BCI Marketplace
Spinal Cord Interface trials

Precise Robotically IMplanted Brain-Computer InterfacE

RecruitingNCT06429735Phase: NAStarted 2024-01-09

Summary

The PRIME Study is a first-in-human early feasibility study to evaluate the initial clinical safety and device functionality of the Neuralink N1 Implant and R1 Robot device designs in participants with tetraparesis or tetraplegia. The N1 Implant is a skull-mounted, wireless, rechargeable implant connected to electrode threads that are implanted in the brain by the R1 Robot, a robotic electrode thread inserter.

Eligibility

Sex
ALL
Min Age
22 Years
Max Age
75 Years

Inclusion Criteria: * Severe quadriplegia (tetraplegia) due to spinal cord injury or amyotrophic lateral sclerosis (ALS) for at least 1 year without improvement, where quadriplegia is defined as having very limited or no hand, wrist, and arm movement and all levels below * Life expectancy ≥ 12 mont

Locations

Barrow Neurological Institute
Phoenix, Arizona, United States
University of Miami
Miami, Florida, United States

Interested in participating? View the full study details on ClinicalTrials.gov:

View on ClinicalTrials.gov →